{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T13:15:08Z","timestamp":1768742108057,"version":"3.49.0"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2018,5,9]],"date-time":"2018-05-09T00:00:00Z","timestamp":1525824000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPPGH5321"],"award-info":[{"award-number":["OPPGH5321"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1127988"],"award-info":[{"award-number":["OPP1127988"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The World Health Organization recently prequalified a typhoid conjugate vaccine (TCV), recommending its use in persons \u22656 months to 45 years residing in typhoid fever (TF)\u2013endemic areas. We now need to consider how TCVs can have the greatest impact in the most vulnerable populations.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The Typhoid Fever Surveillance in Africa Program (TSAP) was a blood culture-based surveillance of febrile patients from defined populations presenting at healthcare facilities in 10 African countries. TF and invasive non-typhoidal Salmonella (iNTS) disease incidences were estimated for 0\u201310 year-olds in one-year age increments.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Salmonella Typhi and iNTS were the most frequently isolated pathogens; 135 and 94 cases were identified, respectively. Analysis from three countries was excluded (incomplete person-years of observation (PYO) data). Thirty-seven of 123 TF cases (30.1%) and 71\/90 iNTS disease cases (78.9%) occurred in children aged &amp;lt;5 years. No TF and 8\/90 iNTS infections (8.9%) were observed in infants aged &amp;lt;9 months. The TF incidences (\/100 000 PYO) for children aged &amp;lt;1 year and 1 to &amp;lt;2 years were 5 and 39, respectively; the highest incidence was 304 per 100 000 PYO in 4 to &amp;lt;5 year-olds. The iNTS disease incidence in the defined age groups ranged between 81 and 233 per 100 000 PYO, highest in 1 to &amp;lt;2 year-olds. TF and iNTS disease incidences were higher in West Africa.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>High burden of TF detected in young children strengthens the need for TCV introduction. Given the concurrent iNTS disease burden, development of a trivalent vaccine against S. Typhi, S. Typhimurium, and S. Enteritidis may be timely in this region.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciy386","type":"journal-article","created":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T19:10:06Z","timestamp":1524856206000},"page":"1824-1830","source":"Crossref","is-referenced-by-count":14,"title":["Determining the Best Immunization Strategy for Protecting African Children Against Invasive <i>Salmonella<\/i> Disease"],"prefix":"10.1093","volume":"67","author":[{"given":"Hyon Jin","family":"Jeon","sequence":"first","affiliation":[{"name":"International Vaccine Institute, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gi Deok","family":"Pak","sequence":"additional","affiliation":[{"name":"International Vaccine Institute, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin","family":"Im","sequence":"additional","affiliation":[{"name":"International Vaccine Institute, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellis","family":"Owusu-Dabo","sequence":"additional","affiliation":[{"name":"Kumasi Center for Collaborative Research in Tropical Medicine, Kumasi, Ghana"},{"name":"Departments of Global and International Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaw","family":"Adu-Sarkodie","sequence":"additional","affiliation":[{"name":"Departments of Clinical Microbiology, School of Medical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Gassama Sow","sequence":"additional","affiliation":[{"name":"Institute Pasteur de Dakar"},{"name":"Universit\u00e9 Cheikh Anta Diop de Dakar, Senegal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdramane","family":"Bassiahi Soura","sequence":"additional","affiliation":[{"name":"Institut Sup\u00e9rieur des Sciences de la Population, University of Ouagadougou, Burkina Faso"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagla","family":"Gasmelseed","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Gezira, Wad Medani, Sudan"},{"name":"Faculty of Science, University of Hafr Al Batin, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen H","family":"Keddy","sequence":"additional","affiliation":[{"name":"National Institute for Communicable Diseases, Johannesburg, South Africa"},{"name":"Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morten","family":"Bjerregaard-Andersen","sequence":"additional","affiliation":[{"name":"Bandim Health Project, Bissau, Guinea-Bissau"},{"name":"Research Center for Vitamins and Vaccines, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Konings","sequence":"additional","affiliation":[{"name":"International Vaccine Institute, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abraham","family":"Aseffa","sequence":"additional","affiliation":[{"name":"Armauer Hansen Research Institute, ALERT Campus, Addis Ababa, Ethiopia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A","family":"Crump","sequence":"additional","affiliation":[{"name":"Kilimanjaro Christian Medical Centre, Moshi, Tanzania"},{"name":"Division of Infectious Diseases and International Health, Duke University Medical Center"},{"name":"Duke Global Health Institute, Duke University, Durham, North Carolina"},{"name":"Centre for International Health, University of Otago, Dunedin, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Chon","sequence":"additional","affiliation":[{"name":"International Vaccine Institute, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert F","family":"Breiman","sequence":"additional","affiliation":[{"name":"Global Health Institute, Emory University, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Se Eun","family":"Park","sequence":"additional","affiliation":[{"name":"International Vaccine Institute, Seoul, Republic of Korea"},{"name":"Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ligia Maria","family":"Cruz Espinoza","sequence":"additional","affiliation":[{"name":"International Vaccine Institute, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye Jin","family":"Seo","sequence":"additional","affiliation":[{"name":"International Vaccine Institute, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"May","sequence":"additional","affiliation":[{"name":"Bernhard Nocht Institute for Tropical Medicine, Hamburg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian G","family":"Meyer","sequence":"additional","affiliation":[{"name":"Institute of Tropical Medicine, Eberhard-Karls University T\u00fcbingen, Germany"},{"name":"Duy Tan University, Da Nang, Vietnam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason R","family":"Andrews","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Geographic Medicine, Stanford University, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ursula","family":"Panzner","sequence":"additional","affiliation":[{"name":"International Vaccine Institute, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera","family":"von Kalckreuth","sequence":"additional","affiliation":[{"name":"International Vaccine Institute, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas F","family":"Wierzba","sequence":"additional","affiliation":[{"name":"International Vaccine Institute, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rapha\u00ebl","family":"Rakotozandrindrainy","sequence":"additional","affiliation":[{"name":"University of Antananarivo, Madagascar"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordon","family":"Dougan","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Cambridge, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myron M","family":"Levine","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Maryland School of Medicine, Baltimore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim","family":"Hombach","sequence":"additional","affiliation":[{"name":"World Health Organization, Geneva, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerome H","family":"Kim","sequence":"additional","affiliation":[{"name":"International Vaccine Institute, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D","family":"Clemens","sequence":"additional","affiliation":[{"name":"International Centre for Diarrheal Disease Research, Bangladesh, Dhaka"},{"name":"Fielding School of Public Health, University of California, Los Angeles"},{"name":"Korea University School of Medicine, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Baker","sequence":"additional","affiliation":[{"name":"Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam"},{"name":"Department of Medicine, University of Cambridge, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Marks","sequence":"additional","affiliation":[{"name":"International Vaccine Institute, Seoul, Republic of Korea"},{"name":"Department of Medicine, University of Cambridge, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,5,9]]},"reference":[{"key":"2024111411404186400_CIT0001","doi-asserted-by":"crossref","first-page":"e310","DOI":"10.1016\/S2214-109X(17)30022-0","article-title":"Incidence of invasive Salmonella disease in sub-Saharan Africa: a multicentre population-based surveillance study","volume":"5","author":"Marks","year":"2017","journal-title":"Lancet Glob Health"},{"key":"2024111411404186400_CIT0002","doi-asserted-by":"crossref","first-page":"e969","DOI":"10.1016\/S2214-109X(17)30328-5","article-title":"Updated estimates of typhoid fever burden in sub-Saharan Africa","volume":"5","author":"Kim","year":"2017","journal-title":"Lancet Glob Health"},{"key":"2024111411404186400_CIT0003","doi-asserted-by":"crossref","first-page":"e570","DOI":"10.1016\/S2214-109X(14)70301-8","article-title":"Burden of typhoid fever in low-income and middle-income countries: a systematic, literature-based update with risk-factor adjustment","volume":"2","author":"Mogasale","year":"2014","journal-title":"Lancet Glob Health"},{"key":"2024111411404186400_CIT0004","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1086\/596208","article-title":"Nontyphoidal Salmonella serovars cause different degrees of invasive disease globally","volume":"199","author":"Langridge","year":"2009","journal-title":"J Infect Dis"},{"key":"2024111411404186400_CIT0005","doi-asserted-by":"crossref","first-page":"941","DOI":"10.3201\/eid2106.140999","article-title":"Global burden of invasive nontyphoidal Salmonella disease, 2010","volume":"21","author":"Ao","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"2024111411404186400_CIT0006","doi-asserted-by":"crossref","first-page":"e0005376","DOI":"10.1371\/journal.pntd.0005376","article-title":"The burden of typhoid fever in low- and middle-income countries: a meta-regression approach","volume":"11","author":"Antill\u00f3n","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"2024111411404186400_CIT0007","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0140-6736(16)31460-X","article-title":"Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"388","author":"GBD 2015 DALYs and HALE Collaborators","year":"2016","journal-title":"Lancet"},{"key":"2024111411404186400_CIT0008","volume-title":"GAVI Alliance board meeting","author":"GAVI Alliance","year":"2011"},{"key":"2024111411404186400_CIT0009","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/cid\/civ295","article-title":"Safety and immunogenicity of a Vi polysaccharide-tetanus toxoid conjugate vaccine (Typbar-TCV) in healthy infants, children, and adults in typhoid endemic areas: a multicenter, 2-cohort, open-label, double-blind, randomized controlled phase 3 study","volume":"61","author":"Mohan","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2024111411404186400_CIT0010","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/S0264-410X(99)00231-5","article-title":"Duration of efficacy of Ty21a, attenuated Salmonella Typhi live oral vaccine","volume":"17","author":"Levine","year":"1999","journal-title":"Vaccine"},{"key":"2024111411404186400_CIT0011","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1056\/NEJM198710293171801","article-title":"Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella Typhi: a preliminary report","volume":"317","author":"Acharya","year":"1987","journal-title":"N Engl J Med"},{"key":"2024111411404186400_CIT0012","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0140-6736(87)91316-X","article-title":"Protective activity of Vi capsular polysaccharide vaccine against typhoid fever","volume":"2","author":"Klugman","year":"1987","journal-title":"Lancet"},{"key":"2024111411404186400_CIT0013","first-page":"153","article-title":"Typhoid vaccines: WHO position paper\u2014March 2018","volume":"93","author":"WHO","year":"2018","journal-title":"Wkly Epidemiol Rec"},{"key":"2024111411404186400_CIT0014","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1056\/NEJM200104263441701","article-title":"The efficacy of a Salmonella Typhi Vi conjugate vaccine in two-to-five-year-old children","volume":"344","author":"Lin","year":"2001","journal-title":"N Engl J Med"},{"key":"2024111411404186400_CIT0015","volume-title":"Summary of the October 2017 meeting of the Strategic Advisory Group of Experts on Immunization Strategic Advisory Group of Experts (SAGE) on Immunization 2017","author":"World Health Organization","year":"2017"},{"key":"2024111411404186400_CIT0016","volume-title":"Typhoid vaccine prequalified","author":"World Health Organization","year":"2018"},{"key":"2024111411404186400_CIT0017","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1016\/S0140-6736(17)32407-8","article-title":"Typhoid vaccine development with a human challenge model","volume":"390","author":"Feasey","year":"2017","journal-title":"Lancet"},{"key":"2024111411404186400_CIT0018","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.4161\/hv.29054","article-title":"Vaccines against invasive Salmonella disease: current status and future directions","volume":"10","author":"MacLennan","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"2024111411404186400_CIT0019","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1586\/14760584.2013.845529","article-title":"Development of Vi conjugate\u2014a new generation of typhoid vaccine","volume":"12","author":"Szu","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"2024111411404186400_CIT0020","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1016\/j.vaccine.2016.03.072","article-title":"Nontyphoidal Salmonella disease: current status of vaccine research and development","volume":"34","author":"Tennant","year":"2016","journal-title":"Vaccine"},{"key":"2024111411404186400_CIT0021","doi-asserted-by":"crossref","first-page":"494","DOI":"10.4161\/hv.19158","article-title":"Glycoconjugate vaccine strategies for protection against invasive Salmonella infections","volume":"8","author":"Simon","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"2024111411404186400_CIT0022","unstructured":"Levine\n              MM\n            , SimonR, TennantSM, et al\n          A broad-spectrum vaccine to prevent invasive Salmonella disease in Sub-Saharan Africa. In: 10th International Conference on Typhoid and Other Invasive Salmonelloses 2017; 2017; Kampala, Uganda."},{"key":"2024111411404186400_CIT0023","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1093\/cid\/civ693","article-title":"The typhoid fever surveillance in Africa Program (TSAP): clinical, diagnostic, and epidemiological methodologies","volume":"62","author":"von Kalckreuth","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2024111411404186400_CIT0024","doi-asserted-by":"crossref","first-page":"e29119","DOI":"10.1371\/journal.pone.0029119","article-title":"Population-based incidence of typhoid fever in an urban informal settlement and a rural area in Kenya: implications for typhoid vaccine use in Africa","volume":"7","author":"Breiman","year":"2012","journal-title":"PLoS One"},{"key":"2024111411404186400_CIT0025","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0140-6736(98)09001-1","article-title":"Typhoid fever in children aged less than 5 years","volume":"354","author":"Sinha","year":"1999","journal-title":"Lancet"},{"key":"2024111411404186400_CIT0026","doi-asserted-by":"crossref","first-page":"644","DOI":"10.4269\/ajtmh.2000.62.644","article-title":"The epidemiology of typhoid fever in the Dong Thap Province, Mekong Delta region of Vietnam","volume":"62","author":"Lin","year":"2000","journal-title":"Am J Trop Med Hyg"},{"key":"2024111411404186400_CIT0027","doi-asserted-by":"crossref","first-page":"e0003619","DOI":"10.1371\/journal.pntd.0003619","article-title":"Typhoid fever in young children in Bangladesh: clinical findings, antibiotic susceptibility pattern and immune responses","volume":"9","author":"Khanam","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"2024111411404186400_CIT0028","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2471\/BLT.06.039818","article-title":"A study of typhoid fever in five Asian countries: disease burden and implications for controls","volume":"86","author":"Ochiai","year":"2008","journal-title":"Bull World Health Organ"},{"key":"2024111411404186400_CIT0029","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1093\/cid\/civ893","article-title":"The relationship between invasive nontyphoidal Salmonella disease, other bacterial bloodstream infections, and malaria in sub-Saharan Africa","volume":"62","author":"Park","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2024111411404186400_CIT0030","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/07853890.2017.1421320","article-title":"Maternal immunization: where are we now and how to move forward","volume":"50","author":"Vojtek","year":"2018","journal-title":"Ann Med"},{"key":"2024111411404186400_CIT0031","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1128\/JCM.36.6.1683-1687.1998","article-title":"Quantitation of bacteria in blood of typhoid fever patients and relationship between counts and clinical features, transmissibility, and antibiotic resistance","volume":"36","author":"Wain","year":"1998","journal-title":"J Clin Microbiol"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/67\/12\/1824\/26826264\/ciy386.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/67\/12\/1824\/26826264\/ciy386.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T12:12:42Z","timestamp":1731586362000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/67\/12\/1824\/4994193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,9]]},"references-count":31,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,5,9]]},"published-print":{"date-parts":[[2018,11,28]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciy386","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,12,15]]},"published":{"date-parts":[[2018,5,9]]}}}